These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 24345876

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
    Gong YL, Yang ZC, Yin SP, Liu MX, Zhang C, Luo XQ, Peng YZ.
    Zhonghua Shao Shang Za Zhi; 2016 Sep 20; 32(9):529-35. PubMed ID: 27647068
    [Abstract] [Full Text] [Related]

  • 3. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine.
    Peschel A, Jack RW, Otto M, Collins LV, Staubitz P, Nicholson G, Kalbacher H, Nieuwenhuizen WF, Jung G, Tarkowski A, van Kessel KP, van Strijp JA.
    J Exp Med; 2001 May 07; 193(9):1067-76. PubMed ID: 11342591
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. An in vitro resistance study of levofloxacin, ciprofloxacin, and ofloxacin using keratitis isolates of Staphylococcus aureus and Pseudomonas aeruginosa.
    Kowalski RP, Pandya AN, Karenchak LM, Romanowski EG, Husted RC, Ritterband DC, Shah MK, Gordon YJ.
    Ophthalmology; 2001 Oct 07; 108(10):1826-9. PubMed ID: 11581056
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Theta-defensins: cyclic antimicrobial peptides produced by binary ligation of truncated alpha-defensins.
    Selsted ME.
    Curr Protein Pept Sci; 2004 Oct 07; 5(5):365-71. PubMed ID: 15544531
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vitro antimicrobial activity of defensins against ocular pathogens.
    Cullor JS, Mannis MJ, Murphy CJ, Smith WL, Selsted ME, Reid TW.
    Arch Ophthalmol; 1990 Jun 07; 108(6):861-4. PubMed ID: 2112378
    [Abstract] [Full Text] [Related]

  • 17. Antibiotic resistance in clinical isolates of Acinetobacter baumannii, Pseudomonas aeruginosa, and Staphylococcus aureus does not impact sensitivity to human beta defensin 4.
    Supp DM, Gardner J, Klingenberg JM, Neely AN.
    Burns; 2009 Nov 07; 35(7):949-55. PubMed ID: 19501982
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Delafloxacin: a novel fluoroquinolone with activity against methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa.
    Ocheretyaner ER, Park TE.
    Expert Rev Anti Infect Ther; 2018 Jul 07; 16(7):523-530. PubMed ID: 29911455
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.